Harrow to Present at Leerink Partner’s 2026 Global Healthcare Conference

Company Overview - Harrow, Inc. is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products for various eye conditions including dry eye disease, wet age-related macular degeneration, cataracts, refractive errors, glaucoma, and other ocular surface and retina diseases [2] - The company was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes [2] Upcoming Events - Management will present at Leerink Partner's 2026 Global Healthcare Conference on March 10, 2026, at 8:40 AM ET in Miami, Florida [1] - The presentation will be webcast live and available for replay on the company's website for approximately 90 days following the event [1]